SG
Sudheer Guntupalli
About Sudheer Guntupalli
Data last updated:
Sudheer Guntupalli is a Director at Karthavya Infracorp Private Limited (since 2018), Designated Partner at Art Achem Labs Llp (since 2024) and Director at Tarak Securities Private Limited (since 2021). The companies operate in Real Estate and Construction, Pharma and Financial Services. The largest current company by reported revenue is Karthavya Infracorp Private Limited at ₹85,960 (FY 2025). Earlier, Sudheer Guntupalli was a Director at Jy Pharma Private Limited (2022–2025) and Director at Raveez Pharma Private Limited (2021–2025) and 1 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Karthavya Infracorp Private Limited U74999TG2018PTC124010 | Director | 25 Apr 2018 | 2018 | ₹85,960 (FY 2025) | Active |
| Art Achem Labs Llp ACK-8888 | Designated Partner | 17 Dec 2024 | 2024 | Active | |
| Tarak Securities Private Limited U65900TG2021PTC155989 | Director | 14 Oct 2021 | 2021 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Jy Pharma Private Limited U24233TG2016PTC103819 | Director | 05 Mar 2022 | 2016 | ₹11.31 Cr (FY 2024) | Active |
| Raveez Pharma Private Limited U24299TG2021PTC155832 | Director | 11 Oct 2021 | 2021 | ₹19.14 Cr (FY 2025) | Active |
| Narmadaria Laboratories Private Limited U24304AP2017PTC106547 | Director | 25 Aug 2017 | 2017 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sudheer Guntupalli
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gudipudi Srikanth | 08115967 | Karthavya Infracorp Private Limited | Director |
| Harikrishna Bellamkonda | 08122994 | Karthavya Infracorp Private Limited | Director |
| Narendra Bellamkonda | 08115966 | Karthavya Infracorp Private Limited | Director |
| Radha Krishna Gadiparthi | 08115965 | Karthavya Infracorp Private Limited , Tarak Securities Private Limited | Managing Director |
| Edala Amrutha | 10874753 | Art Achem Labs Llp | Designated Partner |
| Koteswari Guntupalli | 09360613 | Tarak Securities Private Limited | Director |
| Suneel Kumar Guntupalli | 07311964 | Tarak Securities Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sudheer Guntupalli
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sudheer Guntupalli
Sudheer Guntupalli currently holds 3 directorships: Karthavya Infracorp Private Limited (Director, since 25 Apr 2018, revenue ₹85,960 (FY 2025)); Art Achem Labs Llp (Designated Partner, since 17 Dec 2024); Tarak Securities Private Limited (Director, since 14 Oct 2021).
Sudheer Guntupalli was first appointed on 25 Aug 2017 as Director at Narmadaria Laboratories Private Limited. The most recent appointment on record is 17 Dec 2024 at Art Achem Labs Llp.
Sudheer Guntupalli held 3 earlier board appointments: Jy Pharma Private Limited (Director, 05 Mar 2022 to 18 Jul 2025); Raveez Pharma Private Limited (Director, 11 Oct 2021 to 18 Jul 2025); Narmadaria Laboratories Private Limited (Director, 25 Aug 2017 to 09 Oct 2021).
The current boards of Sudheer Guntupalli's companies include Gudipudi Srikanth (Karthavya Infracorp Private Limited), Harikrishna Bellamkonda (Karthavya Infracorp Private Limited), Narendra Bellamkonda (Karthavya Infracorp Private Limited), Radha Krishna Gadiparthi (Karthavya Infracorp Private Limited), Edala Amrutha (Art Achem Labs Llp), Koteswari Guntupalli (Tarak Securities Private Limited), among others.